Metastatic castration-resistant prostate cancer (mCRPC) is a severe form of late-stage disease where the tumor can no longer ...

According to Vesprini, the most common problem most men experience is that the prostate continues growing. While it might be ...

Lisa Bancroft is among thousands of people who have been tested for the faulty BRCA gene since its discovery 30 years ago.

Men who undergo prostate cancer treatment face a greatly increased risk of life-altering, long-term complications, a new study finds.

The treatment landscape for patients with prostate cancer, especially individuals with advanced disease, has dramatically changed in recent years. However, aside from drug or hormonal therapies, other ...

Researchers from the George Washington University and the Washington DC Veterans Affairs Medical Center have published a case ...

But advanced prostate cancer, which has spread beyond the prostate to other parts of the body, remains notoriously elusive and resourceful when it’s attacked, resisting surgery and drugs that ...

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve ...

Treatment for prostate cancer includes surgery, chemotherapy, immunotherapy, radiation or targeted drug therapy. An estimated one in eight men will be diagnosed with prostate cancer, but only one ...

Precision Drug Olaparib May Be Effective Without Hormone Therapy for Some Men With Biochemically Recurrent Prostate Cancer Aug. 22, 2024 — The anti-cancer drug olaparib may be effective in ...

Prostate cancer patients may have long-term complications from treatment ... Nov. 7 (UPI) -- The U.S. Food and Drug ...

There was an outpouring of support when the six-time Olympic gold medalist revealed last month that he had been handed a ...